XenoTech

Do you have questions about our new tiered study design options? Join Dr. Joanna Barbara, Kansas City Site Lead for BioIVT’s ADME Research Services and Products, for a live webinar presentation followed by Q&A on July 27th at 11am ET to learn more about how the new tiers work, the benefits of each tier, and how to decide which tier is right for you: https://hubs.ly/Q01XhVVC0

With over 3500 respondents to our industry survey on when and why researchers are running various studies, including , and , 96% of respondents said they had experienced negative repercussions from postponing these studies.

Take a look at the survey results infographic to read about when most researchers are performing ADME/ & testing, see what the top 4 repercussions and risks are from postponing, and the top 3 benefits to running more testing during preclinical research: https://bioivt.com/resources/articles-publications?entry=vSvbCm8TSoCORIsRweJjT&utm_source=XTsocial&utm_medium=XTsocial&utm_campaign=XTFacebook&utm_id=XTFacebook&utm_term=IndustrySurvey